Discussion Forum ¨Market Size and Innovation in the Pharmaceutical Industry"

Date

13 Apr 2012 22:00

Section

Innovation & Enterprise

Event Location

Brussels

Event Description

Presented by
Professor Paul Seabright (Toulouse School of Economics and CEPR)
 
Chaired by
Professor Patrick Legros (ECARES, ULB and CEPR)
 
Venue:
Registration and buffet lunch 12:15. 
Presentation and Discussion 13:00-14:00 .
 
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy. In this presentation, based on a policy paper co-authored by Pierre Dubois, Wing Man Wynne Lam, Olivier de Mouzon and Fiona Scott-Morton, Paul Seabright will explore the elasticity of innovation and its implications and relevance to policy discussion.
 
Should you require further assistance, please contact Nadine Clarke, nclarke@cepr.org or +44 20 7183 8808

Jobs

ISS - Institutional Shareholder Services
Junior Research Analyst – Israeli market
ISS - Institutional Shareholder Services
Accountant - Buchhalter/in
EDAA - European Interactive Digital Advertising Alliance
Communications Coordinator
European Schoolnet
Project Officer Trainee
EEB - European Environmental Bureau
Communications Assistant (Intern)
EIT Digital Alumni
Community Manager